Tracking Federal Purchases to Fight the Coronavirus

The federal government is spending billions of dollars to combat the coronavirus. Explore who the U.S. is buying from, what it’s buying and how much it’s paying.

by Moiz Syed and Derek Willis, May 27, 2020. Updated Oct. 1, 2021

$39.9B
Amount Committed
18,233
Contracts
8,263
Vendors
4,097
Sole-Source Contracts

Examples of What the U.S. Has Bought

Top Spending Categories

Biggest Contracts

Vendor Description Total Committed
LEIDOS BIOMEDICAL RESEARCH, INC. Operation of Government Owned Contractor Operated R&D Facilities $938M
RER SOLUTIONS, INC. Financial Services $800M
JANSSEN PHARMACEUTICALS INC Drugs and Biologicals $690M
EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC Biomedical Advanced Development R&D $686M
PHILIPS NORTH AMERICA LLC Medical and Surgical Instruments, Equipment and Supplies $647M

Where Vendors Are Located

State Vendors Total Committed
Virginia 739 $6.29B
Maryland 497 $3.98B
California 820 $3.16B
Texas 555 $2.32B
Illinois 242 $2.13B
Icons by Haisam Hussein, special to ProPublica.
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.
Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page